stoxline Quote Chart Rank Option Currency Glossary
Evofem Biosciences, Inc. (EVFM)
0.011  0.001 (5.77%)    06-21 15:51
Open: 0.011
High: 0.0116
Volume: 349,915
Pre. Close: 0.0104
Low: 0.0105
Market Cap: 1(M)
Technical analysis
2023-05-19 4:37:27 PM
Short term     
Mid term     
Targets 6-month :  0.03 1-year :  0.04
Resists First :  0.02 Second :  0.03
Pivot price 0.01
Supports First :  0.01 Second :  0.01
MAs MA(5) :  0.01 MA(20) :  0.01
MA(100) :  0.03 MA(250) :  0.24
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  7 D(3) :  8.7
RSI RSI(14): 39.5
52-week High :  1.57 Low :  0.01
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ EVFM ] has closed above bottom band by 17.7%. Bollinger Bands are 61.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.02 - 0.02 0.02 - 0.02
Low: 0.01 - 0.01 0.01 - 0.01
Close: 0.02 - 0.02 0.02 - 0.02
Company Description

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.

Headline News

Thu, 20 Jun 2024
Do Options Traders Know Something About Evofem Biosciences (EVFM) Stock We Don't? - Yahoo News Australia

Wed, 19 Jun 2024
Evofem Biosciences Announces Uplisting to OTCQB - Quantisnow

Wed, 19 Jun 2024
Evofem Biosciences Announces Strong Second Quarter 2022 Financial Results and Affirms 2022 Guidance - Quantisnow

Wed, 19 Jun 2024
Evofem Biosciences Announces Approval of Phexxi in Nigeria - Quantisnow

Wed, 19 Jun 2024
Evofem Announces Successful Debt Restructuring - Quantisnow

Wed, 19 Jun 2024
Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder Value - Quantisnow

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Shares Out 216 (M)
Shares Float 0 (M)
Held by Insiders 0.1 (%)
Held by Institutions 4.4 (%)
Shares Short 8,680 (K)
Shares Short P.Month 17,820 (K)
Stock Financials
EPS -1.4
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.76
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0.05
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio -0.02
PEG Ratio 0
Price to Book value -0.03
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2018-01-17
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android